CSII
13560475186
Approved small_molecule completed
Quick answer
CSII for Diabetes Mellitus, Type 2 is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed